artenimol has been researched along with artemisinin in 147 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (6.80) | 18.7374 |
1990's | 23 (15.65) | 18.2507 |
2000's | 15 (10.20) | 29.6817 |
2010's | 74 (50.34) | 24.3611 |
2020's | 25 (17.01) | 2.80 |
Authors | Studies |
---|---|
Benedetti, P; Bizzarri, BM; Botta, L; Cesarini, S; Cirigliano, A; Filippi, S; Fiorucci, D; Negri, R; Paiardini, A; Rinaldi, T; Saladino, R; Zippilli, C | 1 |
Li, XQ; Liu, XX; Wei, MX; Yang, JH; Yang, PW; Yu, JY; Zhang, MW | 1 |
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M | 1 |
Bhakuni, RS; Gaur, R; Malik, FA; Pathania, AS; Verma, RK | 1 |
Dong, G; Liu, N; Sheng, C; Wang, Y; Wu, S | 1 |
Athanassopoulos, CM; Kokkinogouli, V; Lamprou, M; Magoulas, GE; Pantazaka, E; Papadimitriou, E; Papaioannou, D; Skondra, L; Tsigkou, T; Tsoukala, P | 1 |
Bai, L; Gong, J; Jin, Y; Peng, T; Shi, J; Tong, R; Wei, X; Zhou, Y | 1 |
He, Y; Hu, P; Yang, X; Yu, Z; Zhang, N | 1 |
He, Y; Li, G; Li, S; Meng, Q; Sun, D; Yang, X; Yuan, S | 1 |
Çapcı Karagöz, A; Efferth, T; Friedrich, O; Gruber, L; Hahn, F; Hampel, F; Kappes, B; Klein, V; Leidenberger, M; Marschall, M; Reiter, C; Seo, EJ; Tsogoeva, SB | 1 |
Chang, L; Ding, C; Feng, LS; Gao, C; Wu, X; Xu, Z; Yan, XF; Zhao, F | 1 |
Ahmad, F; Giri, SK; Gour, R; Kartha, KPR; Lal Karna, SK; Pokharel, YR; Prajapati, SK | 1 |
Liu, Y; Xu, Z; Zhao, SJ | 1 |
Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
Aratikatla, EK; Asad, M; Bhattacharya, AK; Datta, G; Kalamuddin, M; Malhotra, P; Mohmmed, A; Rana, KC; Sundararaman, S | 1 |
Leskovac, V; Peggins, JO | 1 |
Gosser, DK; Meshnick, SR; Zhang, F | 1 |
Ayalp, A; Bishop, SJ; el-Feraly, FS; Tawfik, AF | 1 |
Song, ZY; Zhao, KC | 2 |
Gu, HM; Peters, W; Warhurst, DC | 2 |
Li, ZL; Peters, W; Robinson, BL; Warhurst, DC | 1 |
Ashmore, RW; Halverson, JM; Lin, AJ; Ridder, WE; Smyth, MH; Theoharides, AD; Zhou, ZM | 1 |
Cooke, DW; Durack, DT; Lallinger, GJ | 1 |
Chen, YX; Ji, RY; Li, Y; Yu, PL | 2 |
Ellis, DS; Gu, HM; Li, ZL; Peters, W; Robinson, BL; Tovey, G; Warhurst, DC | 1 |
Gu, HM; Li, ZL; Peters, W; Warhurst, DC | 1 |
Ager, AL; Klayman, DL; Lin, AJ | 1 |
Fu, LC; Guo, XB; Jian, HX; Li, GQ; Wang, XH | 1 |
Janse, CJ; Kos, J; Lugt, CB; Waters, AP | 1 |
Gao, HL; Long, ZZ; Xie, SS; Yang, SX | 1 |
Avery, MA; Bonk, JD; Chong, WK; Goins, DK; Khan, I; Mehrotra, S; Milhous, W; Miller, R; Venkatesan, S; Wyandt, C | 1 |
Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
Benakis, A; Loutan, L; Paris, M; Plessas, CT; Plessas, ST | 1 |
Heppner, DG; Kawamoto, F; Nguyen, TD; Sookto, P; Trieu, NT; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Kyle, DE; Lin, AJ; Zikry, AB | 1 |
Butter, JJ; Portier, EJ; van Agtmael, MA; van Boxtel, CJ | 1 |
Berens, RL; Curiel, TJ; Krug, EC; Nash, PB | 1 |
Bhisutthibhan, J; Carlton, J; Dame, JB; Hossler, PA; Meshnick, SR; Pan, XQ; Walker, DJ; Yowell, CA | 1 |
Li, Y; Wu, YL | 1 |
Le Bras, J | 1 |
McLean, WG; Ward, SA | 1 |
Looareesuwan, S; Wilairatana, P | 1 |
Eggelte, TA; van Agtmael, MA; van Boxtel, CJ; Vuong, TD | 1 |
Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 1 |
Dodd, CC; Edwards, G; McLean, WG; Park, BK; Sadler, CJ; Smith, SL; Ward, SA | 1 |
Kollaritsch, H; Krudsood, S; Looareesuwan, S; Noedl, H; Wernsdorfer, WH; Wiedermann, G; Wilairatana, P | 1 |
Ashton, M; Davis, TM; Hai, TN; Huong, DX; Ilett, KF; Zhang, SQ | 1 |
Tu, Y | 1 |
Mankhetkorn, S; Reungpatthanaphong, P | 1 |
Basilico, N; Haynes, RK; Monti, D; Olliaro, P; Parapini, S; Taramelli, D | 1 |
Brewer, TG; Kyle, DE; Peggins, JO; Teja-Isavadharm, P; Webster, HK; White, NJ | 1 |
Folb, PI; Smith, P; Waako, PJ | 1 |
Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I | 1 |
Gottstein, B; Hemphill, A; Keiser, J; Lany, C; Ortega-Mora, LM; Roethlisberger, C; Spicher, M; Stadelmann, B | 1 |
Hou, J; Wang, D; Wang, H; Zhang, R | 1 |
Lai, CS; Mansor, SM; Muniandy, A; Nair, NK; Navaratnam, V; Olliaro, PL | 1 |
Song, JP; Tan, B; Trung, TN; Van Phuc, D | 1 |
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
Lacoste, E; Lai, H; Nakase, I; Sasaki, T; Singh, NP | 1 |
Arinaitwe, E; Bigira, V; Dorsey, G; Kakuru, A; Kamya, M; Sandison, T; Tappero, JW; Verret, WJ; Wanzira, H | 1 |
Björkman, A; Ferreira, PE; Gil, JP; Jörnhagen, L; Kone, A; Malmberg, M; Nosten, F; Petzold, M; Schmidt, BA; Veiga, MI | 1 |
Ferreira, JF; Lai, HC; Park, JS; Singh, NP | 1 |
Abu-Bakar, N; Bottova, I; Crespo-Ortiz, MP; Kenny, S; Klonis, N; Rosenthal, PJ; Tilley, L | 1 |
Akao, N; Anyan, WK; Asahi, H; Ayi, I; Boakye, DA; Kumagai, T; Kwansa-Bentum, B; Ohta, N; Otchere, J; Suzuki, T; Wilson, MD | 1 |
Du, F; Liu, T; Wan, Y; Xing, J; Zhu, F | 1 |
Jessing, KK; Juhler, RK; Strobel, BW | 1 |
Du, F; Liu, T; Xing, J; Zhu, F | 1 |
Gerhardt, TE; Kim, BJ; Lai, HC; Park, JS; Sasaki, T; Singh, NP; Wang, S | 1 |
Basilico, N; Corbett, Y; D'Alessandro, S; Finaurini, S; Haynes, RK; Olliaro, P; Parapini, S; Taramelli, D | 1 |
Goodlett, DR; Kirby, BJ; Wan, Y; Whittington, D; Xing, J | 1 |
Baldwin, AS; Dan, HC; Gu, AD; Guo, Z; Hao, W; Wan, YY; Wang, Y; Zhao, YG | 1 |
Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM | 1 |
Kan, WJ; Li, MM; Song, JS; Yu, PX; Yu, WY; Zhao, F | 1 |
Efferth, T; Eichhorn, T; Schneider, D; Veerappan, A; Zeino, M | 1 |
Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
Abiola, A; Faye, B; Folly, K; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, LA; Ndiaye, M; Sow, D; Sylla, K; Tine, RC | 1 |
Ashton, M; Ericsson, T; Hoffmann, KJ; Sundell, J; Torkelsson, A | 1 |
Li, GX; Wang, W; Wang, YH; Xu, FL; Zhang, XG; Zhao, SS | 1 |
Chen, K; Cui, L; Fan, Q; Feng, G; Hao, M; Lin, Y; Sun, L; Wu, Y; Yang, Z; Zhao, Z | 1 |
Achan, J; Arinaitwe, E; Charlebois, E; Clark, TD; Dorsey, G; Havlir, D; Ikilezi, G; Kakuru, A; Kamya, MR; Muhindo, MK; Mwangwa, F; Rosenthal, PJ; Ruel, T; Tappero, JW | 1 |
Cheng, Z; Jiang, X; Liu, R | 1 |
Amaratunga, C; Fairhurst, RM; Neal, AT | 1 |
Chen, N; Cheng, Q; Gatton, ML; Kyle, DE; LaCrue, AN; Teuscher, F; Waters, NC | 1 |
Lai, HC; Park, J; Sasaki, T; Singh, M; Singh, NP | 1 |
Batty, KT; Senarathna, SM | 1 |
Basilico, N; Bosisio, E; Colombo, E; Dell'Agli, M; Haynes, RK; Magenta, D; Parapini, S; Sangiovanni, E; Taramelli, D | 1 |
Diep, NK; Du, ZJ; Fukumoto, Y; Inokuchi, T; Kiguchi, R; Nokami, J; Świtalska, M; Wang, L; Wang, N; Wietrzyk, J | 1 |
Baker, M; Bousema, T; Cairns, M; D'Alessandro, U; Ferguson, NM; Ghani, AC; Griffin, JT; Hugo, P; Jagoe, G; Okell, LC; Tarning, J; Ubben, D | 1 |
Lai, HC; Park, J; Sasaki, T; Singh, NP | 1 |
Bhattacharjee, S; Chotivanich, K; Dondorp, AM; Emrich, S; Estiu, G; Ghorbal, M; Haldar, K; Liu, H; Lopez-Rubio, JJ; Mbengue, A; Mohandas, N; Nguon, C; Njimoh, DL; Pandharkar, T; Pfrender, M; Rizk, SS; Ryan, Y; Stahelin, RV; Wiest, O | 1 |
Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
Bouth, DM; Char, MC; Domergue, A; Duru, V; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Song, L; Tarning, J; Taylor, WR; Witkowski, B | 1 |
Brashear, A; Cabrera, M; Cui, L; Gupta, B; Hu, Y; Kemirembe, K; Li, X; Liang, X; Miao, J; Shrestha, S; Sun, X; Wang, Y; Wang, Z; Wu, Y; Yang, Z; Zhang, Y | 1 |
d'Alessandro, U; Dahal, P; Dorsey, G; Guerin, PJ; Nsanzabana, C; Price, RN; Sibley, CH; Stepniewska, K; Talisuna, AO | 1 |
Bonfill, M; Cusido, RM; Dilshad, E; Mirza, B; Ramirez Estrada, K | 1 |
Baird, JK; Boni, MF; Dondorp, AM; Farrar, J; Lam, HM; Nguyen, TD; Olliaro, P; Thwaites, GE; White, NJ | 1 |
Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
Fowkes, FJI; Jittamala, P; McGready, R; Moore, KA; Nosten, F; Paw, MK; Pimanpanarak, M; Rijken, MJ; Simpson, JA; White, NJ; Wiladphaingern, J | 1 |
Beeching, NJ; Bell, DJ; Chiodini, PL; Lalloo, DG; Shingadia, D; Whitty, CJM | 1 |
Cai, X; Cheramy, J; Dezhahang, Z; Poopari, MR; Savin, A; Xu, Y; Zhang, Y | 1 |
Cao, P; Charman, SA; Creek, DJ; Giannangelo, C; Klonis, N; McCaw, J; Tilley, L; Xie, SC; Yang, T | 1 |
Aderoyeje, T; Adewoye, EO; Akano, K; Ayede, AI; Fatunmbi, B; Ntadom, G; Sowunmi, A | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Chavchich, M; Chen, N; Cheng, Q; Gray, KA; Gresty, KJ; Gutteridge, CE; Peatey, CL; Waters, NC; Zhang, V | 1 |
De Smet, M; Dondorp, A; Etienne, W; Falq, G; Imwong, M; Kindermans, JM; Nguon, C; Rekol, H; Van Den Bergh, R | 1 |
Iyengar, K; Roepe, PD; Siriwardana, A | 1 |
Bouhired, S; Duparc, S; Goyal, N; Green, JA; Hussaini, A; Jones, SW; Koh, GC; Kostov, I; Mohamed, K; Taylor, M; Wolstenholm, A | 1 |
Han, F; Lee, IS | 1 |
Rogerson, SJ; Unger, HW | 1 |
Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
Khositnithikul, R; Mungthin, M; Sitthichot, N; Suwandittakul, N; Ward, SA; Watanatanasup, E | 1 |
Dehaen, W; Hayat, MQ; Iram, S; Jana, S; Pannecouque, C; Thomas, J | 1 |
Combrinck, JM; Cooper, RA; Cowell, AN; Dhingra, SK; Egan, TJ; Fidock, DA; Gupta, P; Henrich, PP; Hoke, JM; Mok, S; Okombo, J; Redhi, D; Stegman, ML; Winzeler, E; Yeo, T | 1 |
Ang, X; Bifani, P; Bodenreider, C; Bonamy, GMC; Chavchich, M; Dembele, L; Diagana, TT; Edstein, MD; Fidock, DA; Lim, MY; Nosten, F; Russell, BM; Selva, JJ; Straimer, J; Yeung, BKS | 1 |
Aweeka, F; Conrad, MD; Dorsey, G; Foster, M; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Legac, J; Mota, D; Nayebare, P; Rosenthal, PJ; Tukwasibwe, S; Tumwebaze, P; Wallender, E; Whalen, M | 1 |
Anh, CX; Birrell, GW; Chavchich, M; Edstein, MD; Quang, NN; Rowcliffe, K; Travers, T; van Breda, K | 1 |
Cao, P; Dini, S; Fowkes, FJI; McCaw, JM; Price, RN; Simpson, JA; van der Pluijm, RW; Zaloumis, S | 1 |
Dai, R; Dai, T; Guo, Z; Jiang, W; Xie, Y | 1 |
Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
Benthani, FA; Bian, ZX; Chen, GQ; Jiang, X; Liang, D; Wu, J | 1 |
Guan, J; Huang, P; Li, F; Liu, L; Liu, Z; Lu, L; Qi, X; Su, T; Wang, D; Wang, Y | 1 |
Bienvenu, AL; Bonnot, G; Kouakou, YI; Lavoignat, A; Leboucher, G; Picot, S; Tod, M | 1 |
Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
Anderson, TJC; Button-Simons, KA; Cassady, Z; Checkley, LA; Davis, SZ; Ferdig, MT; Foster, GJ; McDew-White, M; Nosten, FH; Shoue, DA; Sievert, MAC; Singh, PP; Vendrely, KM | 1 |
Boonhok, R; Cabrera, M; Cao, Y; Cui, L; Liang, X; Mbenda, HGN; Miao, J; Min, H; Qin, J; Siddiqui, FA; Wang, M; Zhu, X | 1 |
Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S | 1 |
Boydston, EA; Fidock, DA; Gnädig, NF; Harding, CR; Herneisen, AL; Lourido, S; Markus, BM; Okombo, J; Petrova, B; Sidik, SM; Ward, KE | 1 |
Gille, L; Machín, L; Monzote, L; Nápoles, R | 1 |
Boaventura, S; Gadelha, FR; Garcia, VL; Grazzia, N; Miguel, DC | 1 |
Fidock, DA; Huang, Y; Nair, MS; Polyak, SJ; Towler, MJ; Wagoner, J; Weathers, PJ | 1 |
Coghi, P; Gianoncelli, A; Mastinu, A; Memo, M; Ng, JPL; Ribaudo, G; Wong, VKW; Yang, LJ | 1 |
Ashley, EA; Aung, H; Aung, Y; Day, NPJ; Dondorp, AM; Heaton, J; Hlaing, T; Imwong, M; Indrasuta, C; Khant, ZS; Kyaw, TT; Maung, SM; McLean, ARD; Phyo, AK; Smithuis, FM; Soe, K; Swe, MMM; Tun, KM; Tun, NN; von Seidlein, L; White, NJ | 1 |
Cui, Z; Jiang, T; Li, C; Li, L; Li, S; Ma, J; Qin, T; Shi, H; Tang, T; Wang, H; Xu, W; Zhou, H | 1 |
Arora, P; Malhotra, P; Mohmmed, A; Mukhtar, O; Narwal, M; Thakur, V | 1 |
Chen, Y; Cheng, Y; Li, P; Liu, H; Lu, X; Ma, Y; Song, C; Wang, Y; Zhang, Z | 1 |
Cao, X; Hu, D; Huang, M; Jiang, Y; Ma, Y; Shi, Y; Song, X | 1 |
Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA | 1 |
Barman, M; Bhandari, V; Dandasena, D; Kamble, S; Sharma, P; Singh, S; Subudhi, M; Suresh, A | 1 |
Baird, JK; Berni, A; Budiman, W; Cedar, E; Chand, K; Crenna-Darusallam, C; Duparc, S; Ekawati, LL; Elyazar, I; Fernando, D; Fletcher, K; Goyal, N; Green, JA; Instiaty, I; Jones, S; Kleim, JP; Lardo, S; Martin, A; Noviyanti, R; Prasetya, CB; Rolfe, K; Santy, YW; Satyagraha, AW; Sharma, H; Soebandrio, A; Subekti, D; Sutanto, I; Tan, LK; Taylor, M | 1 |
Bailly, J; Bei, AK; Coppée, R; Diallo, MA; Diédhiou, Y; Dièye, B; Diongue, K; Doderer-Lang, C; Fall, A; Garba, MN; Gaye, A; Mama, A; Mbaye, A; Mbaye, AM; Ménard, D; Ndiaye, D; Ndiaye, IM; Ndiaye, T; Thiaw, AB; Tine, A; Yade, MS | 1 |
D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A | 1 |
15 review(s) available for artenimol and artemisinin
Article | Year |
---|---|
Tackling Fungal Resistance by Biofilm Inhibitors.
Topics: Animals; Antifungal Agents; Biofilms; Drug Discovery; Drug Resistance, Fungal; Fungi; Humans; Models, Molecular; Mycoses; Small Molecule Libraries | 2017 |
Inhibitors of phosphodiesterase as cancer therapeutics.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neoplasms; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship | 2018 |
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Humans; Structure-Activity Relationship; Tetrazoles | 2019 |
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
Studies of qinghaosu and its active derivatives in biological materials and their pharmacokinetics.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Sesquiterpenes; Structure-Activity Relationship | 1989 |
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Evaluation; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Medicine, Chinese Traditional; Sesquiterpenes | 1998 |
The rational use of qinghaosu and its derivatives: what is the future of new compounds?
Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug and Narcotic Control; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Registries; Sesquiterpenes; Suppositories; Thailand | 1998 |
Rectal administration of artemisinin derivatives for the treatment of malaria.
Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drugs, Chinese Herbal; Female; Malaria, Falciparum; Mice; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.
Topics: Africa; Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prospective Studies; Quinolines | 2015 |
Prevention and control of malaria in pregnancy - new threats, new opportunities?
Topics: Adult; Animals; Antimalarials; Artemisinins; Culicidae; Drug Combinations; Drug Resistance; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Primary Prevention; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Drug Monitoring; Drug Resistance; Humans; Malaria; Malaria, Falciparum | 2019 |
17 trial(s) available for artenimol and artemisinin
Article | Year |
---|---|
Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Sesquiterpenes; Tablets | 1997 |
Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Half-Life; Humans; Linear Models; Male; Metabolic Clearance Rate; Sesquiterpenes | 2001 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in c
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Electrochemistry; Humans; Solid Phase Extraction | 2009 |
A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Integrative Medicine; Malaria, Falciparum; Male; Quinolines; Treatment Outcome; Young Adult | 2009 |
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Infant; Malaria; Malnutrition; Parasitemia; Quinolines | 2011 |
Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Population Surveillance; Quinolines; Senegal; Young Adult | 2013 |
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda | 2014 |
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Topics: Adolescent; Adult; Antigens, Bacterial; Antigens, Surface; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Treatment Failure; Young Adult | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
Topics: Adolescent; Amodiaquine; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Prognosis; Quinolines; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Healthy Volunteers; Humans; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Quinolines; Young Adult | 2016 |
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2020 |
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Cluster Analysis; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mass Drug Administration; Myanmar; Primaquine; Quinolines; Young Adult | 2021 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies | 2023 |
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines | 2023 |
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome | 2023 |
115 other study(ies) available for artenimol and artemisinin
Article | Year |
---|---|
Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.
Topics: | 2020 |
Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Proliferation; Drug Screening Assays, Antitumor; Furans; Humans; MCF-7 Cells; Piperazines | 2021 |
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes | 2016 |
Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Proliferation; Chalcone; Chemistry Techniques, Synthetic; Dimerization; Drug Design; HL-60 Cells; Humans; Membrane Potential, Mitochondrial | 2016 |
Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Chick Embryo; Chickens; Chorioallantoic Membrane; Dimerization; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Neovascularization, Physiologic; Polyamines; Reactive Oxygen Species | 2017 |
Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dimerization; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; PC12 Cells; Rats; Structure-Activity Relationship | 2018 |
Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Fluorine; G1 Phase Cell Cycle Checkpoints; Humans; Molecular Structure | 2018 |
Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
Topics: Animals; Anisoles; Antimalarials; Antineoplastic Agents; Antiviral Agents; Artemisinins; Benzofurans; Benzoquinones; Biological Products; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Cytomegalovirus; Humans; Molecular Conformation; Plasmodium falciparum | 2018 |
Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.
Topics: Antineoplastic Agents; Artemisinins; Cell Cycle; Cell Death; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; PC-3 Cells; Reactive Oxygen Species; Structure-Activity Relationship; Wound Healing | 2019 |
Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Topics: Antimalarials; Artemisinins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Heme; Malaria; Molecular Structure; Organophosphonates; Parasitic Sensitivity Tests; Peptides; Plasmodium falciparum; Polymerization; Structure-Activity Relationship; Vinyl Compounds | 2021 |
Hepatic metabolism of artemisinin drugs--III. Induction of hydrogen peroxide production in rat liver microsomes by artemisinin drugs.
Topics: Animals; Antimalarials; Artemisinins; Hydrogen Peroxide; Kinetics; Male; Microsomes, Liver; NADP; Rats; Rats, Inbred Strains; Sesquiterpenes | 1992 |
Hemin-catalyzed decomposition of artemisinin (qinghaosu).
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Ferric Compounds; Hemin; Oxidation-Reduction; Sesquiterpenes | 1992 |
Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice.
Topics: Animals; Antibody Formation; Antimalarials; Artemisinins; Carrageenan; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Immunosuppressive Agents; Inflammation; Male; Mice; Sesquiterpenes | 1990 |
Hemolysis induced by artemisinin and its derivatives in vitro.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Hemoglobins; Hemolysis; Humans; Pyrans; Sesquiterpenes | 1986 |
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Determination of dihydroqinghaosu in blood by pyrolysis gas chromatography/mass spectrometry.
Topics: Animals; Artemisinins; Gas Chromatography-Mass Spectrometry; Male; Rabbits; Sesquiterpenes | 1988 |
In vitro sensitivity of Naegleria fowleri to qinghaosu and dihydroqinghaosu.
Topics: Amoeba; Amphotericin B; Animals; Artemisinins; Sesquiterpenes | 1987 |
[Studies on analogs of qinghaosu (artean-nuin, artemisinine). III. The synthesis of diacid esters and mono esters of dihydroqinghaosu].
Topics: Animals; Antimalarials; Artemisinins; Esters; Plasmodium berghei; Sesquiterpenes | 1985 |
The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; Cell Membrane; Endoplasmic Reticulum; Erythrocytes; Malaria; Mice; Microscopy, Electron; Plasmodium berghei; Plasmodium falciparum; Protein Biosynthesis; Ribosomes; Sesquiterpenes; Time Factors | 1985 |
[Studies on analogs of qinghaosu (artemisinine, arteannuin). IV. Synthesis of derivatives of qinghaosu containing halogen, nitrogen and sulfur heteroatoms].
Topics: Animals; Antimalarials; Artemisinins; Mice; Sesquiterpenes | 1985 |
Rapid action of Qinghaosu and related drugs on incorporation of [3H]isoleucine by Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Isoleucine; Kinetics; Plasmodium falciparum; Protein Biosynthesis; Pyrans; Sesquiterpenes; Tritium | 1983 |
Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Hypoxanthine; Hypoxanthines; Plasmodium falciparum; Pyrans; Sesquiterpenes; Time Factors | 1983 |
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Gels; Malaria; Mice; Plasmodium berghei; Sesquiterpenes; Structure-Activity Relationship | 1994 |
Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.
Topics: Antimalarials; Antiprotozoal Agents; Artemisinins; Artesunate; China; Clinical Trials as Topic; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Cerebral; Malaria, Falciparum; Sesquiterpenes; Suppositories; Tablets | 1994 |
Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Malaria; Mice; Plasmodium berghei; Rats; Rats, Wistar; Sesquiterpenes | 1994 |
[Pharmacokinetics of dihydroqinghaosu in human volunteers and comparison with qinghaosu].
Topics: Administration, Oral; Adult; Artemisinins; Biological Availability; Estrenes; Humans; Male; Radioimmunoassay; Sesquiterpenes; Suppositories; Tablets | 1993 |
Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Antimalarials; Artemisinins; Artesunate; B-Lymphocytes; Bone Marrow Transplantation; Concanavalin A; DNA; Dose-Response Relationship, Immunologic; Female; Hypersensitivity, Delayed; Immunity, Cellular; Interleukin-2; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sesquiterpenes; Spleen; T-Lymphocytes | 1993 |
Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins.
Topics: Animals; Antimalarials; Artemisinins; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Erythrocytes; Humans; Molecular Structure; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1995 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes; Vietnam | 1997 |
Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
Topics: Animals; Antimalarials; Artemisinins; Drug Design; Female; Magnetic Resonance Spectroscopy; Malaria; Mice; Molecular Conformation; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Solubility | 1997 |
Validation of an improved reversed-phase high-performance liquid chromatography assay with reductive electrochemical detection for the determination of artemisinin derivatives in man.
Topics: Antimalarials; Artemisinins; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Sesquiterpenes | 1998 |
Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Drug Resistance; Ethyl Methanesulfonate; Female; Humans; Methylnitronitrosoguanidine; Mice; Mice, Inbred ICR; Mutagenesis; Sesquiterpenes; Toxoplasma; Toxoplasmosis, Animal | 1998 |
The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.
Topics: Amino Acid Sequence; Animals; Antimalarials; Artemisinins; Biomarkers, Tumor; Calcium-Binding Proteins; Cloning, Molecular; Drugs, Chinese Herbal; Erythrocytes; Humans; Models, Chemical; Molecular Sequence Data; Plasmodium falciparum; Protein Binding; Recombinant Proteins; Sequence Alignment; Sesquiterpenes; Tumor Protein, Translationally-Controlled 1 | 1998 |
In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Evaluation, Preclinical; Drug Resistance; France; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes; Travel | 1998 |
In vitro neurotoxicity of artemisinin derivatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cell Differentiation; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Mice; Microscopy, Electron; Neuroblastoma; Neurons; Reproducibility of Results; Sesquiterpenes; Tumor Cells, Cultured | 1998 |
The development of an immunoassay for the detection of artemisinin compounds in urine.
Topics: Adult; Antibodies, Monoclonal; Antimalarials; Artemisinins; Artesunate; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Sesquiterpenes | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro.
Topics: Animals; Antimalarials; Antimetabolites; Antioxidants; Artemether; Artemisinins; Buthionine Sulfoximine; Drug Interactions; Glutathione; Hemin; Humans; Mice; Neurites; Sesquiterpenes; Tumor Cells, Cultured | 2001 |
Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Artemisinins; Azithromycin; Dose-Response Relationship, Drug; Humans; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Thailand | 2001 |
The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu.
Topics: Animals; Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drugs, Chinese Herbal; Humans; Sesquiterpenes | 1999 |
Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.
Topics: Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Drug Resistance, Multiple; Humans; K562 Cells; Membrane Potentials; Mitochondria; Multidrug Resistance-Associated Proteins; Sesquiterpenes; Tumor Cells, Cultured | 2002 |
Artemisinin antimalarials do not inhibit hemozoin formation.
Topics: Antimalarials; Artemisinins; Heme; Hemeproteins; Hemin; Sesquiterpenes | 2003 |
Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Biological Assay; Biotransformation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electrochemistry; Hot Temperature; Humans; In Vitro Techniques; Macaca mulatta; Malaria, Falciparum; Plasmodium falciparum; Reproducibility of Results; Sesquiterpenes | 2004 |
In vitro interactions of Aspilia africana (Pers.) C.D. Adams, a traditional antimalarial medicinal plant, with artemisinin against Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Asteraceae; Drug Interactions; Erythrocytes; India; Medicine, Traditional; Plant Extracts; Plasmodium falciparum; Sesquiterpenes | 2005 |
In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives.
Topics: Albendazole; Animals; Anti-Infective Agents; Antiparasitic Agents; Artemisinins; Drug Therapy, Combination; Echinococcosis; Echinococcus granulosus; Echinococcus multilocularis; Humans; Larva; Mice; Mice, Inbred BALB C; Nitro Compounds; Parasitic Sensitivity Tests; Thiazoles; Treatment Outcome | 2008 |
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Artemether; Artemisinins; Artesunate; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2008 |
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Topics: Adenocarcinoma; Animals; Artemisinins; Female; Injections, Intravenous; Mammary Neoplasms, Experimental; Random Allocation; Rats; Rats, Inbred F344; Transferrin | 2009 |
Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Base Sequence; Drug Resistance; Ethanolamines; Fluorenes; Gene Frequency; Genotype; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2011 |
Cytotoxicity of ethanolic extracts of Artemisia annua to Molt-4 human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Artemisia annua; Artemisinins; Brazil; Cell Death; Cell Line, Tumor; China; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Free Radical Scavengers; Humans; Lethal Dose 50; Leukocytes; Medicine, Chinese Traditional; Plant Leaves; Plants, Medicinal; Time Factors | 2011 |
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.
Topics: Animals; Antimalarials; Artemisinins; Biological Transport, Active; Cysteine Endopeptidases; Endocytosis; Erythrocytes; Gene Deletion; Genes, Protozoan; Hemoglobins; Host-Parasite Interactions; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2011 |
Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based combination therapy deployment.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Community-Based Participatory Research; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Drug Utilization; Female; Ghana; Health Care Surveys; Humans; Infant; Male; Middle Aged; Nurses; Pharmacists; Pharmacy Technicians; Physicians; Practice Patterns, Physicians'; Rural Population; Surveys and Questionnaires; Urban Population | 2011 |
Rapid identification of phase I and II metabolites of artemisinin antimalarials using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange technique.
Topics: Animals; Antimalarials; Artemisinins; Bile; Biotransformation; Chromatography, Liquid; Deuterium Exchange Measurement; Humans; Hydroxylation; Male; Mass Spectrometry; Microsomes, Liver; Rats; Rats, Wistar | 2011 |
Monitoring of artemisinin, dihydroartemisinin, and artemether in environmental matrices using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Topics: Artemether; Artemisia annua; Artemisinins; Chromatography, High Pressure Liquid; Kenya; Plant Extracts; Soil; Tandem Mass Spectrometry | 2011 |
Metabolite identification of artemether by data-dependent accurate mass spectrometric analysis using an LTQ-Orbitrap hybrid mass spectrometer in combination with the online hydrogen/deuterium exchange technique.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Bile; Chromatography, Liquid; Deuterium Exchange Measurement; Hydroxylation; Male; Mass Spectrometry; Methylation; Microsomes, Liver; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2011 |
Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo.
Topics: Alcohols; Animals; Anti-Infective Agents; Antioxidants; Artemisinins; Cell Line, Tumor; Dimerization; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mammary Neoplasms, Animal; Models, Chemical; Rats; Rats, Inbred F344; Time Factors | 2011 |
Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle.
Topics: Artemisinins; Cell Cycle; Cell Differentiation; Erythroid Cells; Flow Cytometry; Humans; K562 Cells; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship | 2012 |
Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
Topics: Antimalarials; Artemisinins; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cells, Cultured; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Hepatocytes; Humans; Kinetics; Liver; Microsomes, Liver; Models, Biological; Oxidoreductases, N-Demethylating; Primary Cell Culture; Recombinant Proteins; RNA, Messenger | 2012 |
Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway.
Topics: Amino Acid Sequence; Animals; Artemisinins; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Signal Transduction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; TOR Serine-Threonine Kinases | 2012 |
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania | 2013 |
[Anti-inflammatory effect and mechanism of artemisinin and dihydroartemisinin].
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Cell Line; Gene Expression; Inflammation Mediators; Interleukin-6; Macrophages; Mice; Nitric Oxide; Tumor Necrosis Factor-alpha | 2012 |
Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin.
Topics: Animals; Artemisinins; Artesunate; Cattle; Drug Therapy, Combination; Hydrophobic and Hydrophilic Interactions; Malaria; Protein Binding; Serum Albumin | 2013 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Microsomes, Liver; Recombinant Proteins; Tandem Mass Spectrometry | 2014 |
Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation.
Topics: Alleles; Antigens, Protozoan; Antimalarials; Artemisinins; DNA, Protozoan; Drug Resistance; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Quinolines; Tetrahydrofolate Dehydrogenase | 2014 |
Comparative studies on the interactions of dihydroartemisinin and artemisinin with bovine serum albumin using spectroscopic methods.
Topics: Artemisinins; Binding Sites; Energy Transfer; Fluorescence; Imaging, Three-Dimensional; Light; Protein Conformation; Scattering, Radiation; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Temperature; Thermodynamics | 2014 |
Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay.
Topics: Antimalarials; Artemisinins; Biological Assay; Cell Survival; Erythrocytes; Flow Cytometry; Fluorescent Dyes; Half-Life; Humans; Life Cycle Stages; Parasitic Sensitivity Tests; Plasmodium falciparum; Staining and Labeling | 2014 |
Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum.
Topics: Acetyl-CoA Carboxylase; Antimalarials; Apicoplasts; Artemisinins; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Erythrocytes; Fatty Acids; Gene Expression Regulation; Humans; Life Cycle Stages; Metabolic Networks and Pathways; Mitochondria; Mitochondrial Proteins; Plasmodium falciparum; Protozoan Proteins; Pyruvates; Transcription, Genetic | 2014 |
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia; Transferrin; Tumor Cells, Cultured | 2014 |
Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.
Topics: Age Factors; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Male; Models, Theoretical | 2014 |
Inhibition of metalloproteinase-9 secretion and gene expression by artemisinin derivatives.
Topics: Artemisinins; Artesunate; Cytokines; Gene Expression Regulation; Humans; Inflammation Mediators; Malaria, Cerebral; Malaria, Falciparum; Matrix Metalloproteinase 9; Monocytes; Plasmodium falciparum; Polymerase Chain Reaction; RNA, Messenger | 2014 |
Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
Topics: Animals; Antineoplastic Agents; Artemisinins; BALB 3T3 Cells; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Mice; Quinolines; Structure-Activity Relationship | 2014 |
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.
Topics: Africa; Antimalarials; Artemisinins; Cost-Benefit Analysis; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Models, Theoretical; Quinolines; Seasons | 2014 |
DNA damage in dihydroartemisinin-resistant Molt-4 cells.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Comet Assay; DNA Damage; Drug Resistance, Neoplasm; Humans; Transferrin | 2015 |
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Resistance; Genome-Wide Association Study; Malaria, Falciparum; Models, Molecular; Mutation; Phosphatidylinositol 3-Kinase; Phosphatidylinositol Phosphates; Phosphoinositide-3 Kinase Inhibitors; Plasmodium falciparum; Protozoan Proteins | 2015 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene.
Topics: Artemisinins; China; Drug Resistance, Multiple; Genotype; Malaria, Falciparum; Mutation; Myanmar; Plasmodium falciparum; Quinolines | 2015 |
Genetic Transformation of Artemisia carvifolia Buch with rol Genes Enhances Artemisinin Accumulation.
Topics: Agrobacterium tumefaciens; Antimalarials; Artemether; Artemisia annua; Artemisinins; Artesunate; Base Sequence; Biosynthetic Pathways; Gene Expression Regulation, Plant; Molecular Sequence Data; Plant Proteins; Plants, Genetically Modified; Transformation, Genetic; Trichomes | 2015 |
Optimum population-level use of artemisinin combination therapies: a modelling study.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Administration Schedule; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2015 |
Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antimalarials; Artemisinins; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Quinine; Thailand | 2016 |
UK malaria treatment guidelines 2016.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Breast Feeding; Child; Child, Preschool; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Travel | 2016 |
IR and Vibrational Circular Dichroism Spectroscopy of Matrine- and Artemisinin-Type Herbal Products: Stereochemical Characterization and Solvent Effects.
Topics: Alkaloids; Artemisinins; Circular Dichroism; Drugs, Chinese Herbal; Hydrogen Bonding; Malaria; Matrines; Molecular Structure; Quinolizines; Sophora | 2016 |
Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
Topics: Antimalarials; Artemisinins; Heterocyclic Compounds; Parasitic Sensitivity Tests; Plasmodium falciparum | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Correlation between Cyclin Dependent Kinases and Artemisinin-Induced Dormancy in Plasmodium falciparum In Vitro.
Topics: Animals; Artemisinins; Cyclin-Dependent Kinases; Cyclins; Genes, Protozoan; Life Cycle Stages; Parasitemia; Parasites; Plasmodium falciparum; Protein Kinase Inhibitors; Transcription, Genetic | 2016 |
Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asymptomatic Diseases; Cambodia; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Real-Time Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2016 |
Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype.
Topics: Adamantane; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inactivation, Metabolic; Lethal Dose 50; Microbial Sensitivity Tests; Peroxides; Plasmodium falciparum; Spiro Compounds | 2016 |
Microbial transformation of the antimalarial sesquiterpene endoperoxide dihydroartemisinin.
Topics: Absidia; Antimalarials; Artemisinins; Biotransformation; Molecular Structure; Oxidation-Reduction; Penicillium chrysogenum | 2017 |
Influence of the
Topics: Alleles; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gene Dosage; Genotyping Techniques; Inhibitory Concentration 50; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Thailand | 2017 |
Application of the Triazolization Reaction to Afford Dihydroartemisinin Derivatives with Anti-HIV Activity.
Topics: Amines; Anti-HIV Agents; Artemisinins; Catalysis; Cell Line; HIV; Humans; Inhibitory Concentration 50; Ketones; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Triazoles | 2017 |
A Variant PfCRT Isoform Can Contribute to
Topics: Antimalarials; Artemisinins; Cambodia; Drug Resistance; Gene Editing; Humans; Lethal Dose 50; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins; Quinolines | 2017 |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.
Topics: Animals; Antimalarials; Artemisinins; Cell Cycle Checkpoints; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrazines | 2017 |
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
Topics: Amodiaquine; Antimalarials; Area Under Curve; Artemisinins; Biotransformation; Drug Administration Schedule; Drug Combinations; Half-Life; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Tablets; Young Adult | 2018 |
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Theoretical; Plasmodium falciparum; Quinolines | 2018 |
Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Chromatography, Liquid; Drug Monitoring; Injections, Intravenous; Male; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.
Topics: Animals; Antineoplastic Agents; Artemisinins; Autophagy; Cell Line, Tumor; Female; Ferroptosis; Homeostasis; Humans; Iron; Iron-Regulatory Proteins; Lysosomes; Mice, Nude; Neoplasms; Response Elements | 2020 |
Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Artemisinins; Artesunate; Bacterial Adhesion; Cell Line, Tumor; Cytokines; Helicobacter Infections; Helicobacter pylori; Humans; Mice, Inbred C57BL; Microbial Sensitivity Tests; NF-kappa B; Reactive Oxygen Species; Stomach Neoplasms | 2019 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput.
Topics: Antimalarials; Artemisinins; Benzothiazoles; Diamines; Drug Resistance; Erythrocytes; Flow Cytometry; Fluorescent Dyes; Half-Life; Humans; Malaria, Falciparum; Organic Chemicals; Parasitemia; Plasmodium falciparum; Povidone; Quinolines; Real-Time Polymerase Chain Reaction; Silicon Dioxide | 2020 |
Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Organisms, Genetically Modified; Plasmodium falciparum; Protozoan Proteins | 2020 |
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility.
Topics: Antimalarials; Artemisinins; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Resistance; Gene Knockout Techniques; Genetic Testing; Heme; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Toxoplasma | 2020 |
Leishmania amazonensis response to artemisinin and derivatives.
Topics: Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Leishmania mexicana; Mice; Mice, Inbred BALB C; Parasite Load; Trypanocidal Agents | 2021 |
Dihydroartemisinin, an active metabolite of artemisinin, interferes with Leishmania braziliensis mitochondrial bioenergetics and survival.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Energy Metabolism; Hydrogen Peroxide; Leishmania braziliensis; Macrophages; Mitochondria; Succinates | 2021 |
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Topics: Animals; Antiviral Agents; Artemisia annua; Artemisinins; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Flavonoids; Humans; Plant Extracts; Plant Leaves; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication | 2021 |
Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD).
Topics: Angiotensin-Converting Enzyme 2; Antimalarials; Antiviral Agents; Artemisinins; Binding Sites; Chloroquine; COVID-19 Drug Treatment; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Cell Death; Female; Ferroptosis; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasites; Piperazines; Reactive Oxygen Species; Sorafenib | 2022 |
A Plasmodium falciparum ubiquitin-specific protease (PfUSP) is essential for parasite survival and its disruption enhances artemisinin efficacy.
Topics: Animals; Antimalarials; Artemisinins; Drug Resistance; Humans; Malaria; Parasites; Plasmodium falciparum; Proteasome Endopeptidase Complex; Ubiquitin; Ubiquitin-Specific Proteases | 2023 |
Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Topics: Artemether; Artemisinins; Artesunate; Caspase 3; Drugs, Chinese Herbal; ErbB Receptors; Humans; Interleukin-17; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Osteoporosis; Prolactin | 2022 |
Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against
Topics: Animals; Artemisinins; Ferroptosis; Humans; Reactive Oxygen Species; Toxoplasma; Toxoplasmosis | 2022 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Artemisinin derivatives induce oxidative stress leading to DNA damage and caspase-mediated apoptosis in Theileria annulata-transformed cells.
Topics: Animals; Apoptosis; Artemisinins; Artesunate; Caspases; Cattle; DNA Damage; Oxidative Stress; Reactive Oxygen Species; Theileria annulata | 2023 |
Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.
Topics: Animals; Antimalarials; Artemisinins; Drug Resistance; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Protozoan Proteins; Senegal; Uganda | 2023 |